anabolic steroids and SARMs are not the same drug class. Anabolic androgenic steroids are testosterone related active drugs or drug like substances. SARMs, or selective androgen receptor modulators, are chemicals designed to act on androgen receptors with more tissue selectivity in theory. That selectivity does not make online SARM products safe, approved or predictable. FDA warns that SARMs are not FDA approved and are linked with serious reported harms.
This comparison reviews class identity, receptor targeting, approval status, sport rules and health risk signals. It does not rank SARMs, list vendors, name cycle combinations, offer dosing, or treat SARMs as a safer replacement for medical care.
Sources checked 2026-09-08. Law, sport rules and product availability can change. Check the exact compound, jurisdiction and sport authority before relying on any status claim.
What do the terms mean?
Anabolic androgenic steroids are a broad class of testosterone related hormones and synthetic derivatives. Some have approved medical uses under clinician supervision. Many are also misused for muscle gain, strength, body composition or appearance. In nonmedical contexts, AAS may involve oral tablets, injectable products, topical testosterone products, veterinary associated substances or designer agents.
SARMs are selective androgen receptor modulators. The basic claim is targeted androgen receptor activity: enough androgen like signaling in tissues such as muscle or bone, with fewer unwanted effects in other tissues. That is a development goal, not a consumer safety finding. FDA consumer material describes SARMs as chemicals that mimic testosterone and anabolic steroids, states that they are not FDA approved, and warns that online promotion can make them appear safe and effective when they are not.
The comparison counts because people often search it as a safety shortcut: steroids are harsh, SARMs are cleaner. That shortcut is not evidence. Different drug classes can still share androgen pathway risks, product label uncertainty and sport rule consequences.
How do they compare across matched points?
| Attribute | Anabolic steroids | SARMs |
|---|---|---|
| Drug class | testosterone related anabolic androgenic drugs or derivatives. | Selective androgen receptor modulators designed for targeted receptor effects. |
| Medical status | Some steroid medicines have approved uses under professional supervision. | FDA says SARMs are not FDA approved and cannot be legally marketed in the US as dietary supplements or drugs at this time. |
| Marketing claim | Often promoted for strength, size, cutting, bulking or physique change. | Often promoted as research only products, supplement style products or easier alternatives. |
| Evidence limit | Medical use data does not check high exposure nonmedical use. | Selective receptor theory does not check retail SARM product claims. |
| Risk overlap | Hormone, cardiovascular, liver, fertility, mood and dependence concerns can apply. | FDA lists serious reported concerns including heart attack or stroke risk, liver injury, infertility, sexual dysfunction and psychiatric effects. |
| Sport status | Many AAS are prohibited in sport. | WADA lists SARMs such as ostarine, ligandrol, RAD140, S-23 and YK-11 under anabolic agents. |
| Product confidence | Underground products can be counterfeit or contaminated. | Research use or supplement labels may omit warnings or hide true product quality. |
Why is receptor selectivity not a safety promise?
The word selective is the part that attracts many people. It suggests precision, and precision sounds safer. In pharmacology, selectivity is a design goal about how a compound interacts with receptor pathways. It is not proof that the compound is safe in nonmedical use, safe in a teen or young adult, safe when stacked, safe for the liver, safe for fertility, or safe when bought online.
FDA warnings make this boundary plain. The agency says SARMs are potentially dangerous, that it continues to receive adverse event reports, and that social media promotion can contribute to availability and misleading confidence. FDA also notes underreporting may mean the real number of adverse events is higher than reports show.
With anabolic steroids, the evidence trap is different. Some medicines in this wider hormone area have legitimate medical uses. That can make nonmedical users borrow medical legitimacy for a different exposure and purpose. A medically supervised testosterone product for a diagnosed condition is not the same as supraphysiologic AAS use for physique or performance.
What approval and label status counts?
Approval status is one of the cleanest differences. Some anabolic steroid medicines have approved medical uses, with prescription controls and professional oversight. SARMs sold to consumers are a different story. FDA says SARMs are not approved, are considered unapproved drugs, and cannot legally be marketed in the United States as a dietary supplement or drug at this time.
Product labeling can blur this difference. A SARM product might be sold as research use only, not for human consumption, a capsule supplement, a liquid, or a performance product. That label does not prove legal marketing, safe use, quality, identity or absence of contamination. FDA bodybuilding product warnings also show that products sold for physique goals may contain steroids or steroid like substances while being promoted as supplements.
| Claim | What it can mean | What it cannot prove |
|---|---|---|
| FDA approved steroid medicine | A specific medicine may have an approved indication and label. | It does not approve nonmedical bodybuilding exposure. |
| SARM | A compound intended to modulate androgen receptors selectively. | It does not prove safety, legality or effectiveness. |
| Research use only | A seller may be trying to avoid consumer use language. | It does not remove health risk when humans use it. |
| Dietary supplement | A retail category claim. | It does not prove that a steroid like drug is lawful or safe. |
| Lab tested | A claimed analysis may exist. | It does not prove every batch, contaminant or chain of custody. |
How do sport rules treat SARMs?
Sport status is not decided by supplement marketing. The 2026 WADA Prohibited List places SARMs under anabolic agents, naming examples such as andarine, ostarine, ligandrol, RAD140, S-23 and YK-11. The list also covers many anabolic androgenic steroids and not approved substances in separate categories.
For athletes, the practical lesson is simple: a SARM label does not protect against sport rule risk. A product can be sold online, promoted by influencers, missing from a casual list, or marketed as a supplement and still be a banned substance problem. Contamination and undeclared ingredients can add risk beyond the named compound.
Sport rules, criminal law, import law and prescription law are not the same system. A page comparing AAS and SARMs can flag those boundaries, but jurisdiction specific law belongs to the dedicated law page and official legal sources.
Which health risks need matched comparison?
A fair comparison does not pick a safety winner. It asks matched questions: What receptor pathway is affected? What product was used? Was it prescribed? Is there a known dose? Was it stacked with other drugs? What symptoms appeared? What are the person’s cardiovascular, liver, fertility and mental health risks?
| Question | Why it counts for AAS | Why it counts for SARMs |
|---|---|---|
| Heart and blood vessels | AAS class evidence includes lipid, blood pressure, clot and heart concerns. | FDA lists heart attack or stroke risk among serious reported concerns. |
| Liver | Some oral AAS and steroid like products raise liver concern. | FDA lists liver injury and acute liver failure among reported concerns. |
| Hormones and fertility | External androgens can suppress normal hormone signaling and fertility. | FDA lists infertility, sexual dysfunction and testicular shrinkage among concerns. |
| Mood and sleep | AAS misuse can be linked with mood changes, withdrawal and dependence. | FDA lists sleep disturbances and psychosis or hallucinations among concerns. |
| Product quality | Underground AAS can be counterfeit, contaminated or wrongly dosed. | Online SARM products may lack warnings and may not match user assumptions. |
The safest comparison outcome is humility. If a product interacts with androgen pathways and was bought outside medical care, the user may not know enough to assess personal risk risk.
Which marketing claims need pushback?
| Claim | Why it is weak | Better question |
|---|---|---|
| SARMs are safer than steroids | Selective receptor design does not prove consumer safety. | What human evidence, approval status and adverse reports exist? |
| SARMs are not real drugs | FDA treats SARMs sold to consumers as unapproved drugs. | What is the exact compound and regulatory status? |
| Steroids are more predictable | That may be true only for prescribed medicines with known identity. | Is the product pharmacy supplied and monitored? |
| Research only labels avoid risk | The label does not change body exposure when used by humans. | Why is a not approved product being used? |
| Influencer use proves safety | Anecdotes miss hidden harms, underreporting and survivorship bias. | What would a clinician need to know? |
How may clinicians separate the risks?
If someone has used an anabolic steroid, SARM, research chemical or mixed bodybuilding product, a clinician may ask about the claimed substance, route, dates, other substances, alcohol or drug use, symptoms, mental health, blood pressure, liver symptoms, fertility goals and any prior lab results. The goal is not to shame the person. It is to reduce uncertainty.
FDA specifically recommends consumers talk to a health care professional about products used to increase muscle mass or athletic performance. That advice applies strongly when the product was sold online, promoted by social media, labeled as research use only, or taken with other products.
| Information | Why it counts |
|---|---|
| Claimed product name and photos | Labels help identify what was claimed, even when they do not prove contents. |
| Dates and route | Timing and route help connect symptoms, exposure and testing needs. |
| Other substances | Stacks can change liver, heart, mood and hormone effects. |
| Chest, liver, neurologic or psychiatric symptoms | Some signs need urgent care. |
| Fertility and sexual symptoms | Hormonal suppression and recovery can need support. |
What is the plain language answer?
AAS and SARMs are different categories, but the comparison should not be turned into a clean/dirty or safe/unsafe binary. Anabolic steroids have a longer medical and misuse history, with class harms that are well recognized. SARMs are often marketed as selective and modern, but FDA says they are not approved and warns about serious reported adverse effects.
The useful decision is to separate identity from marketing: drug class, exact compound, approval status, sport status, product quality, personal health risk and clinician support. Once those are separated, the idea of choosing a winner becomes less useful than getting the risk question right.
What should you read next?
Which sources support this explanation?
- FDA: Selective Androgen Receptor Modulators warning. Used for SARM approval status, marketing risk and reported health concerns..
- WADA 2026 Prohibited List. Used for Sport status for anabolic agents and named SARMs..
- FDA: Caution: Bodybuilding Products Can Be Risky. Used for Hidden steroid like product and bodybuilding marketing risk..
- FDA: Certain bodybuilding products put consumers at risk for heart attack, stroke, serious liver damage and more. Used for Undeclared anabolic/steroid like ingredient and warning sign context..
- National Athletic Trainers Association position statement on anabolic androgenic steroids. Used for AAS medical, sport and adverse effect context..
- MedlinePlus: Anabolic Steroids. Used for plain language AAS misuse and support context..
- Endocrine Society: Adverse Health Consequences of performance enhancing Drugs. Used for class level performance enhancing drug harm context..